The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia
新型低甲基化药物NTX-301作为单药疗法以及与维奈托克联合治疗急性髓系白血病的临床前疗效
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-022-00664-y
Lim, Byungho; Yoo, Dabin; Chun, Younghwa; Go, Areum; Cho, Kyung-Jin; Choi, Daeun; Jung, Myoung Eun; Lee, Ha Young; Boohaker, Rebecca J; Lee, Jin Soo; Jung, DooYoung; Choi, Gildon